STOCK TITAN

RF Acquisition Corp III SEC Filings

RFAM NASDAQ

Welcome to our dedicated page for RF Acquisition III SEC filings (Ticker: RFAM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on RF Acquisition III's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into RF Acquisition III's regulatory disclosures and financial reporting.

Rhea-AI Summary

RF Acquisition Corp III, a Cayman Islands SPAC, reports early-stage results for the quarter ended June 30, 2026 after completing its IPO in February 2026. The company sold 10,000,000 units at $10.00 each, and together with a 350,000-unit private placement, placed $100,000,000 into a U.S.-based trust account.

As of June 30, 2026, cash held in the trust account was $101,273,496, reflecting interest income, while cash outside the trust was $891,600 and shareholders’ equity was $595,740. The SPAC recorded net income of $566,737 for the quarter and $1,239,770 for the nine months, driven mainly by $870,264 and $1,273,496, respectively, of interest on trust assets and a $422,000 gain from derecognition of an over-allotment option liability, partially offset by general and administrative costs.

The trust backs 10,000,000 public shares classified as redeemable at $10.13 per share. The company has 21 months from the IPO closing to complete a business combination. On July 9, 2026, it signed a Business Combination Agreement with HCC Healthcare Pte. Ltd., valuing HCC Healthcare at a fully diluted equity value of $500,000,000; RF Acquisition Corp III will merge into a HCC Healthcare subsidiary, and each SPAC share will convert into HCC Healthcare shares, with each right converting into one-tenth of a share, subject to customary closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

RF Acquisition Corp III agreed to merge with Singapore-based HCC Healthcare Pte. Ltd. in a SPAC business combination that values HCC Healthcare at $500,000,000 on a fully diluted basis, with each recapitalized Company Ordinary Share valued at $10.00.

Before closing, HCC Healthcare will recapitalize its shares, then RF Acquisition will merge into a Cayman merger subsidiary that remains a wholly owned unit of HCC Healthcare. Each RF Acquisition ordinary share will convert into one HCC Healthcare ordinary share, and each RF Acquisition right will convert into one-tenth of one HCC Healthcare ordinary share.

Closing requires shareholder approvals, effectiveness of a Form F‑4 registration statement, and Nasdaq or NYSE listing approval, among other customary conditions and termination rights. Certain HCC shareholders and the SPAC founder signed voting and lock‑up agreements, generally restricting sales for up to six months post‑closing and granting registration rights. HCC Healthcare operates, on a pro forma basis, an integrated Taiwan long‑term care network with more than 120 facilities and over 9,000 beds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
current report
-
Rhea-AI Summary

RF Acquisition Corp III entered into a Business Combination Agreement with HCC Healthcare. The agreement contemplates a recapitalization valuing HCC Healthcare at $500,000,000 on a fully diluted basis and a merger in which RFAC III will merge into HCC Merger Sub, with Merger Sub surviving as a subsidiary of HCC Healthcare.

Closing is subject to customary conditions including an effective Registration Statement, shareholder approvals, Nasdaq or NYSE listing approval, accuracy of representations, pre-closing covenants, no material adverse effect and absence of legal prohibition. Certain HCC shareholders and the Founder agreed to voting support and six-month lock-ups.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.2%
Tags
merger
Rhea-AI Summary

RF Acquisition Corp III ownership report: AQR Capital Management, LLC and related entities report beneficial ownership of 940,000 ordinary shares, representing 6.75% of the class as of 03/31/2026. The filing states shared voting and dispositive power over those shares across AQR entities.

The disclosure lists AQR Capital Management Holdings, LLC, AQR Capital Management, LLC, and AQR Arbitrage, LLC as filers and notes parent/subsidiary relationships. The report is signed by an authorized signatory on behalf of the AQR entities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

RF Acquisition Corp III, a Cayman Islands-based blank check company, reported net income of $725,986 for the three months and $673,033 for the six months ended March 31, 2026. Results were driven by a $422,000 gain from the change in fair value of the over-allotment liability and $403,232 of interest on IPO proceeds held in trust, partially offset by $152,199 in general and administrative costs.

The company completed its IPO on February 17, 2026, selling 10,000,000 units at $10.00 each and a concurrent private placement of 350,000 units at $10.00, placing $100,000,000 into a U.S.-based trust. As of March 31, 2026, cash in the trust totaled $100,403,232 and cash outside the trust was $933,390, providing working capital while it searches for a target in deep technology sectors in Asia.

The SPAC has 10,000,000 ordinary shares classified as redeemable at $10.04 per share and 3,933,333 non-redeemable ordinary shares outstanding. It has up to 21 months from the IPO closing to complete a business combination, and on March 17, 2026, entered a non-binding letter of intent with a prospective target, with no assurance a definitive deal will follow.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

RF Acquisition Corp III, a newly formed SPAC targeting deep technology businesses in Asia, reported a small net loss of $52,953 for the quarter ended December 31, 2025, reflecting only general and administrative costs.

As of December 31, 2025, the company had total assets of $758,705, all related to deferred offering costs, and a working capital deficit of $299,606 funded by a related-party promissory note and accrued offering costs.

Subsequent to quarter end, on February 17, 2026, the company completed its initial public offering of 10,000,000 units at $10.00 per unit, raising gross proceeds of $100,000,000, and sold 350,000 private placement units for $3,500,000. A total of $100,000,000 was deposited into a U.S. trust account to fund a future business combination, which must be completed within 21 months of the IPO closing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report

FAQ

How many RF Acquisition III (RFAM) SEC filings are available on StockTitan?

StockTitan tracks 6 SEC filings for RF Acquisition III (RFAM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for RF Acquisition III (RFAM)?

The most recent SEC filing for RF Acquisition III (RFAM) was filed on July 21, 2026.